NCT04040452View on ClinicalTrials.gov

Continuous Vs Intermittent Ketorolac for Pain Control in Peds CV Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

June 1, 2026

Study Completion Date

December 1, 2026

Conditions
Congenital Heart Disease in Children
Interventions
DRUG

Continuous ketorolac

Patients randomized for the treatment arm of the study group will receive a continuous infusion of ketorolac plus an intermittent dose of placebo (plasmalyte) for 48 hours.

Trial Locations (1)

85016

RECRUITING

Phoenix Children's Hospital, Phoenix

All Listed Sponsors
lead

Phoenix Children's Hospital

OTHER